A federal judge yesterday denied drug maker Novartis’ request to speed up a hearing on its request that the judge block the government from punishing the company over its denials of 340B pricing when health care providers use contract pharmacies.
…
Blog Posts
U.S. Sen. Mike Braun (R-Ind.) introduced legislation last night to let the federal government audit 340B covered entities to determine how they use net income from drugs bought under the 340B program.
Please Login or Become
The decision by the U.S. Health Resources & Services Administration (HRSA) to refer six drug manufacturers to the U.S. Health and Human Services Department of the Office of The Inspector General (HHS OIG) for refusing to offer 340B discounts to
…
After an initial burst of optimism earlier this year, some health care organizations are having second thoughts about large in-person events for the remainder of 2021 and the start of the new year.
Please Login or
SPONSORED CONTENT by Hannah Drake, Senior Director of Marketing, par8o
340B covered entities strive to ensure they are getting the maximum benefit out of the 340B program in order to help fund services for vulnerable patient populations. For health centers, this means setting up a robust contract pharmacy network.
Surprisingly, more than 70% of par8o’s 340B Referral Capture clients did not
…
The U.S. Health Resources and Services Administration (HRSA) says it plans to resume some onsite 340B compliance audits of covered entities starting in October.
Please Login or Become a Paid Subscriber to View this Content
Hospital trade groups are lodging strong objections to maintaining steep cuts in Medicare Part B reimbursement as part of the Fiscal Year 2022 final rule for the hospital outpatient prospective payment system (OPPS), while the trade group for brand name
…
Q: Where did you grow up?
I was born in Johannesburg, South Africa. When I was two my parents moved to the US. I mostly grew up in Phoenix, AZ.
Q:
…
The U.S. Health Resources & Services Administration (HRSA) today referred six drug manufacturers to the U.S. Health and Human Services Department of the Office of the Inspector General (OIG) regarding their refusal to offer 340B program discounts to 340B covered
…